In MTC cells in vitro, Kunnimalaiyaan et al. [47] have demonstrated that ZM336372 treatment resulted in increasing Raf-1 activation as measured by phosphorylation of ERK1/2. The gene discussed is RAF1; the disease is medullary thyroid gland carcinoma.